Genesis IBRC India Limited announced its unaudited financial results for the third quarter of FY26, revealing continued operational challenges with a net loss of ₹3.18 lakhs for the quarter ended December 31, 2025.

Financial Performance Overview

The company's Q3FY26 results showed a deterioration in financial performance compared to the previous year. The net loss increased to ₹3.18 lakhs from ₹2.65 lakhs in Q3FY25, representing a widening of losses year-over-year.

Nine-Month Performance Analysis

The nine-month period ended December 31, 2025, presented a stark contrast to the previous year's performance. Genesis IBRC India Limited reported a net loss of ₹21.46 lakhs for the nine months of FY26, compared to a net profit of ₹352.70 lakhs in the corresponding period of FY25.

Corporate Governance and Compliance

The Board of Directors of Genesis IBRC India Limited convened on February 14, 2026, to review and approve the quarterly financial results. The meeting commenced at 4:00 PM and concluded at 4:30 PM. Managing Director Poonam Chaturvedi (DIN: 05163733) signed off on the results, ensuring compliance with SEBI regulations.

The financial results were prepared in accordance with Indian Accounting Standards (Ind-AS) and reviewed by the company's statutory auditors as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Capital Structure and Earnings Per Share

Genesis IBRC India Limited maintains a consistent capital structure with a paid-up equity share capital of ₹1,300.00 lakhs, comprising shares with a par value of ₹10 each. The earnings per share (EPS) for Q3FY26 stood at negative ₹0.02 (both basic and diluted), compared to negative ₹0.02 in Q3FY25.

The company operates in a single business segment, and the financial results pertain to this unified operational structure. Genesis IBRC India Limited, formerly known as SSK Lifestyles Limited, continues to navigate operational challenges while maintaining regulatory compliance and transparency in financial reporting.

Genesis IBRC India Limited announced significant corporate developments following its board meeting held on January 28, 2026. The company's board of directors approved a substantial preferential issue and strategic business expansion plans that require shareholder and regulatory approvals.

Preferential Issue Details

The board approved the preferential allotment of equity shares to a diverse group of investors, comprising both promoters and non-promoters.

The investor base includes promoters Mr. Padmanaban Krishnamoorthy and Ms. V. Varalakshmi, along with nine non-promoter investors including Mr. Muhammed Noor Habibullah, Mr. Suresh Kumar Ramani, Mr. Vidhu Mohan Pillai, Dhanesh Advisory LLP, Mr. Ajay Sangani, Mr. Kaushal Ruparel, Mr. Nandlal Chaturvedi, Ms. Poonam Chaturvedi, and Mr. Ravindranath Rajaram.

Capital Structure Enhancement

To accommodate the preferential issue, the board approved a significant increase in the company's authorized share capital.

The board also approved the constitution of a Preferential Issue Committee to handle matters related to the preferential issue and authorized the opening of a separate bank account for this purpose.

Business Expansion Strategy

The company approved a comprehensive alteration to its main object clause, expanding its business scope to include fast-moving consumer goods, commodities, and minerals. The new business activities will encompass:

• FMCG Products: Milk products, breakfast cereals, snacks, personal care items, beverages, cooking oils, and other consumer goods
• Healthcare Products: Over-the-counter medical products, medical devices, and hospital furniture
• Commodities and Minerals: Bitumen, sulphur, iron ore, bauxite, and related products

The expansion strategy aims to leverage the new management's expertise in FMCG, commodities, and minerals sectors, particularly targeting growth opportunities in Middle East markets for Indian FMCG products.

Governance and Approval Process

The board approved a postal ballot process to obtain shareholder approval for the proposed changes. Key appointments and dates include:

The valuation report from the independent registered valuer determined the fair price of INR 10 per equity share for the preferential issue. All proposed changes are subject to approval from shareholders, stock exchanges, and other requisite regulatory authorities including the Ministry of Corporate Affairs.